WASHINGTON (dpa-AFX) - Clinical laboratory, Quest Diagnostics (DGX), said on Thursday that it has appointed current General Diagnostics Executive Vice President James Davis as Chief Executive Officer or CEO-elect with effect from November 1, to succeed Steve Rusckowski. It also said Chief Financial Officer or CFO Mark Guinan will retire in 2022.
Despite the appointment of the new chief executive, Rusckowski, currently Chairman, CEO, and President of the firm, will continue to serve on the Board as Executive Chairman through March 2023.
Davis joined the company in 2013 as Senior Vice President, Diagnostic Solutions. Currently he oversees Quest's general diagnostics business, accounting for over 80 percent of the company's $10.8 billion revenues in 2021.
In addition, Quest said its CFO Mark Guinan, has announced his intention to retire in 2022. Quest has started a search to identify new finance chief.
Copyright(c) 2022 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2022 AFX News
